|
EIF4B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.299360E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.064800E-03 |
| Normal-vs-Stage2 |
4.957600E-02 |
| Normal-vs-Stage3 |
2.923700E-03 |
| Normal-vs-Stage4 |
3.235900E-02 |
| Stage1-vs-Stage2 |
8.195400E-01 |
| Stage1-vs-Stage3 |
7.016200E-01 |
| Stage1-vs-Stage4 |
8.162600E-01 |
| Stage2-vs-Stage3 |
6.531600E-01 |
| Stage2-vs-Stage4 |
9.958800E-01 |
| Stage3-vs-Stage4 |
6.341200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.425200E-04 |
| Normal-vs-AfricanAmerican |
6.280800E-01 |
| Normal-vs-Asian |
3.031500E-02 |
| Caucasian-vs-AfricanAmerican |
2.796900E-03 |
| Caucasian-vs-Asian |
6.510600E-01 |
| AfricanAmerican-vs-Asian |
1.950310E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.384600E-03 |
| Normal-vs-Female |
2.395100E-03 |
| Male-vs-Female |
5.009000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.421300E-03 |
| Normal-vs-Age(41-60Yrs) |
2.863700E-03 |
| Normal-vs-Age(61-80Yrs) |
1.469690E-02 |
| Normal-vs-Age(81-100Yrs) |
2.115900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.148000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.102000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.130600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.369200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.224400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.249800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.483600E-01 |
| Classical-VS-Follicular |
2.219700E-02 |
| Classical-VS-Other |
6.579200E-01 |
| Classical-VS-Normal |
1.458300E-02 |
| Tall-VS-Follicular |
7.493800E-01 |
| Tall-VS-Other |
8.823000E-01 |
| Tall-VS-Normal |
6.544000E-03 |
| Follicular-VS-Other |
7.654400E-01 |
| Follicular-VS-Normal |
6.807900E-04 |
| Other-VS-Normal |
2.140200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.042180E-03 |
| Normal-vs-N1 |
1.504950E-03 |
| N0-vs-N1 |
3.190600E-01 |
|
|
